The latest cancer drugs news
Browsing: Cancer Drug News
FDA approves dual-action drug for patients with previously treated advanced neuroendocrine tumours
Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug…
FDA approves pembrolizumab for HER2 positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1 (CPS ≥1)
On March 19, 2025, the Food and Drug Administration granted traditional approval to pembrolizumab with…
FDA approves vimseltinib for symptomatic tenosynovial giant cell tumour
On February 14, 2025, the Food and Drug Administration approved vimseltinib, a kinase inhibitor, for…
NICE recommends lisocabtagene maraleucel cell therapy for eligible patients with relapsed or refractory large B-cell lymphomas
Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence…
NICE recommends rucaparib as a first-line maintenance treatment for BRCA-negative advanced ovarian cancer
Pharma and GmbH announced today that the UK’s National Institute of Health and Care Excellence…
FDA approves mirdametinib for adult and paediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection
On February 11, 2025, the Food and Drug Administration approved mirdametinib, a kinase inhibitor, for…
FDA approves treosulfan with fludarabine as a preparative regimen for alloHSCT in adult and paediatric patients with AML or MDS
On January 21, 2025, the Food and Drug Administration approved treosulfan, an alkylating agent, with…
FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma
On February 11, 2025, the Food and Drug Administration approved brentuximab vedotin in combination with…
EC approval for blinatumomab in Philadelphia chromosome-negative CD19-positive B-cell precursor acute lymphoblastic leukaemia in the consolidation phase
The European Commission (EC) has approved blinatumomab monotherapy as consolidation therapy for treating adult patients…
Researchers identify inhibitor drugs to treat aggressive breast cancer
A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two…